.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Queensland Health
AstraZeneca
McKesson
Argus Health
Healthtrust
Merck
Daiichi Sankyo
Medtronic
Harvard Business School

Generated: June 26, 2017

DrugPatentWatch Database Preview

Pirbuterol acetate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for pirbuterol acetate and what is the scope of pirbuterol acetate freedom to operate?

Pirbuterol acetate
is the generic ingredient in one branded drug marketed by Valeant Pharms and Medicis, and is included in two NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for pirbuterol acetate.

Summary for Generic Name: pirbuterol acetate

Tradenames:1
Patents:1
Applicants:2
NDAs:2
Drug Master File Entries: see list3
Bulk Api Vendors: see list10
Clinical Trials: see list902
Patent Applications: see list1,345
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:pirbuterol acetate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Pharms
MAXAIR
pirbuterol acetate
AEROSOL, METERED;INHALATION019009-001Dec 30, 1986DISCNNoNo► Subscribe► Subscribe
Medicis
MAXAIR
pirbuterol acetate
AEROSOL, METERED;INHALATION020014-001Nov 30, 1992DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: pirbuterol acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Medicis
MAXAIR
pirbuterol acetate
AEROSOL, METERED;INHALATION020014-001Nov 30, 19924,664,107► Subscribe
Valeant Pharms
MAXAIR
pirbuterol acetate
AEROSOL, METERED;INHALATION019009-001Dec 30, 19863,700,681► Subscribe
Valeant Pharms
MAXAIR
pirbuterol acetate
AEROSOL, METERED;INHALATION019009-001Dec 30, 19864,175,128► Subscribe
Valeant Pharms
MAXAIR
pirbuterol acetate
AEROSOL, METERED;INHALATION019009-001Dec 30, 19863,786,160► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Express Scripts
Healthtrust
McKesson
Boehringer Ingelheim
Chubb
Moodys
Farmers Insurance
Queensland Health
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot